Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Reiterates Buy Rating for Nexxen International with 65 Price Target

Elaine Mendonca by Elaine Mendonca
March 6, 2024
in Breaking News
0
Finance_ projections
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

On March 6, 2024, analyst Laura Martin from Needham reiterated her optimistic stance on Nexxen International (NASDAQ:NEXN), giving it a Buy rating and a price target of $6.5. This reaffirmation underscores her belief in the company’s future performance and growth prospects. With this vote of confidence, Nexxen International is poised for success in the market.

NEXN Stock Shows Positive Momentum, Closing at $5.35 on March 6, 2024

On March 6, 2024, NEXN stock showed positive momentum as it closed at $5.35, marking a 4.09% increase from the previous trading day. This rise in price was significant, especially considering that the stock is currently trading in the middle of its 52-week range and above its 200-day simple moving average. Investors may have been pleased to see NEXN’s price movement on this particular day, as the stock has been performing well in the short term. However, it is important to note that the stock did drop $0.04 in after-hours trading, which could indicate some volatility in the market. Overall, NEXN’s performance on March 6, 2024, suggests that the stock may be gaining momentum and attracting investor interest. It will be interesting to see how the stock continues to perform in the coming days and whether it can sustain this positive momentum. Investors should continue to monitor NEXN’s price movements and any relevant news or developments that could impact the stock’s performance.

NEXN Stock Performance Analysis: Revenue and Net Income Decline in Third Quarter 2024

On March 6, 2024, NEXN stock had mixed performances based on the financial data provided by CNN Money. The total revenue for the company was reported at $335.25 million for the past year, with a significant decrease to $80.09 million in the third quarter. In terms of net income, NEXN reported $22.74 million for the past year, which saw a drastic decrease to -$1.20 million in the third quarter. Earnings per share (EPS) for NEXN stock were reported at $0.30 for the past year, but dropped to -$0.02 in the third quarter. Overall, the financial data for NEXN stock on March 6, 2024, reflects a mixed performance. Investors should carefully analyze these numbers and consider other factors before making any investment decisions related to NEXN stock.

Tags: NEXN
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Technology Cloud computing

TeraWulf Sees Surge in Stock Prices and Promising Outlook for 2024

Biotechnology Market Capitalization

Title Surge in NKGen Biotech Stock Linked to Upcoming Presentation and Penny Stock Status

Cyber-security-technology

GoDaddy Stock Updates Analyst Predicts Potential Increase

Recommended

Thyssenkrupp Stock

Thyssenkrupp’s Restructuring Plan Faces Critical Test

1 week ago
Almonty Stock

Almonty’s Strategic Pivot: From Defense to Fusion Energy

2 months ago
Stride Stock

Stride Faces Investor Backlash Following Platform Failure

4 months ago
Finance_Commercial (2)

Cadre Holdings Announces Public Offering of Common Stock

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Battalion Oil Navigates Debt and Operational Overhaul

Divergent Analyst Views Highlight Coeur Mining’s Strategic Transition

Rocket Lab Stock Attracts Bullish Analyst Sentiment Amid Growth Trajectory

TSMC’s Arizona Expansion Gains Momentum Amid Record Retail Investor Interest

Salesforce Shares Face Pressure from External AI Innovation

UnitedHealth Bets on Artificial Intelligence to Counteract Mounting Pressures

Trending

ImmunityBio Stock
Analysis

Regulatory Rebuke Sends ImmunityBio Shares Tumbling

by Rodolfo Hanigan
March 25, 2026
0

A significant regulatory warning from the U.S. Food and Drug Administration (FDA) has triggered a sharp sell-off...

Realty Income Stock

Realty Income’s Strategic Financing Defies High Interest Rate Environment

March 25, 2026
IBM Stock

IBM Shares Face Pressure from Analyst Downgrades and Acquisition Concerns

March 25, 2026
Battalion Oil Stock

Battalion Oil Navigates Debt and Operational Overhaul

March 25, 2026
Coeur Mining Stock

Divergent Analyst Views Highlight Coeur Mining’s Strategic Transition

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Regulatory Rebuke Sends ImmunityBio Shares Tumbling
  • Realty Income’s Strategic Financing Defies High Interest Rate Environment
  • IBM Shares Face Pressure from Analyst Downgrades and Acquisition Concerns

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com